Fulton Breakefield Broenniman LLC Biogen Inc. Transaction History

Fulton Breakefield Broenniman LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 25, 2021	SELL	$282.99 - $369.05 $165,832 - $216,263	-586 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$259.0 - $414.71 $151,774 - $243,020	586 New	586 $203,000
Q2 2020 Jul 10, 2020	SELL	$258.66 - $342.55 $172,267 - $228,138	-666 Closed	0 $0
Q1 2020 Apr 10, 2020	BUY	$268.85 - $341.04 $179,054 - $227,132	666 New	666 $211,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.